{ "translatorID": "fcf41bed-0cbc-3704-85c7-8062a0068a7a", "label": "PubMed XML", "creator": "Simon Kornblith, Michael Berkowitz, Avram Lyon, and Rintze Zelle", "target": "xml", "minVersion": "2.1.9", "maxVersion": "", "priority": 100, "configOptions": { "dataMode": "xml/dom" }, "inRepository": true, "translatorType": 1, "lastUpdated": "2021-07-21 03:05:39" } /* ***** BEGIN LICENSE BLOCK ***** Copyright © 2017-2020 Simon Kornblith, Michael Berkowitz, Avram Lyon, Sebastian Karcher, and Rintze Zelle This file is part of Zotero. Zotero is free software: you can redistribute it and/or modify it under the terms of the GNU Affero General Public License as published by the Free Software Foundation, either version 3 of the License, or (at your option) any later version. Zotero is distributed in the hope that it will be useful, but WITHOUT ANY WARRANTY; without even the implied warranty of MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE. See the GNU Affero General Public License for more details. You should have received a copy of the GNU Affero General Public License along with Zotero. If not, see . ***** END LICENSE BLOCK ***** */ /******************************* * Import translator functions * *******************************/ function detectImport() { var text = Zotero.read(1000); return text.includes(""); } function processAuthors(newItem, authorsLists) { for (var j = 0, m = authorsLists.length; j < m; j++) { // default to 'author' unless it's 'editor' var type = "author"; if (authorsLists[j].hasAttribute('Type') && authorsLists[j].getAttribute('Type') === "editors") { type = "editor"; } var authors = ZU.xpath(authorsLists[j], 'Author'); for (var k = 0, l = authors.length; k < l; k++) { var author = authors[k]; var lastName = ZU.xpathText(author, 'LastName'); var firstName = ZU.xpathText(author, 'FirstName'); if (!firstName) { firstName = ZU.xpathText(author, 'ForeName'); } var suffix = ZU.xpathText(author, 'Suffix'); if (suffix && firstName) { firstName += ", " + suffix; } if (firstName || lastName) { var creator = ZU.cleanAuthor(lastName + ', ' + firstName, type, true); if (creator.lastName.toUpperCase() == creator.lastName) { creator.lastName = ZU.capitalizeTitle(creator.lastName, true); } if (creator.firstName.toUpperCase() == creator.firstName) { creator.firstName = ZU.capitalizeTitle(creator.firstName, true); } newItem.creators.push(creator); } else if ((lastName = ZU.xpathText(author, 'CollectiveName'))) { // corporate author newItem.creators.push({ creatorType: type, lastName: lastName, fieldMode: 1 }); } } } } function doImport() { var doc = Zotero.getXML(); var pageRangeRE = /(\d+)-(\d+)/g; // handle journal articles var articles = ZU.xpath(doc, '/PubmedArticleSet/PubmedArticle'); for (let i = 0, n = articles.length; i < n; i++) { var newItem = new Zotero.Item("journalArticle"); var citation = ZU.xpath(articles[i], 'MedlineCitation')[0]; var article = ZU.xpath(citation, 'Article')[0]; let title = ZU.xpathText(article, 'ArticleTitle'); if (!title) title = ZU.xpathText(article, 'VernacularTitle'); if (title) { if (title.charAt(title.length - 1) == ".") { title = title.substring(0, title.length - 1); } newItem.title = title; } var fullPageRange = ZU.xpathText(article, 'Pagination/MedlinePgn'); if (fullPageRange) { // where page ranges are given in an abbreviated format, convert to full pageRangeRE.lastIndex = 0; var range; while ((range = pageRangeRE.exec(fullPageRange))) { var pageRangeStart = range[1]; var pageRangeEnd = range[2]; var diff = pageRangeStart.length - pageRangeEnd.length; if (diff > 0) { pageRangeEnd = pageRangeStart.substring(0, diff) + pageRangeEnd; var newRange = pageRangeStart + "-" + pageRangeEnd; fullPageRange = fullPageRange.substring(0, range.index) // everything before current range + newRange // insert the new range + fullPageRange.substring(range.index + range[0].length); // everything after the old range // adjust RE index pageRangeRE.lastIndex += newRange.length - range[0].length; } } newItem.pages = fullPageRange; } // use elocation pii when there's no page range if (!newItem.pages) { newItem.pages = ZU.xpathText(article, 'ELocationID[@EIdType="pii"]'); } var journal = ZU.xpath(article, 'Journal')[0]; if (journal) { newItem.ISSN = ZU.xpathText(journal, 'ISSN'); var abbreviation; if ((abbreviation = ZU.xpathText(journal, 'ISOAbbreviation'))) { newItem.journalAbbreviation = abbreviation; } else if ((abbreviation = ZU.xpathText(article, '//MedlineTA'))) { newItem.journalAbbreviation = abbreviation; } let title = ZU.xpathText(journal, 'Title'); if (title) { title = ZU.trimInternal(title); // Fix sentence-cased titles, but be careful... if (!( // of accronyms that could get messed up if we fix case /\b[A-Z]{2}/.test(title) // this could mean that there's an accronym in the title && (title.toUpperCase() != title // the whole title isn't in upper case, so bail || !(/\s/.test(title))) // it's all in upper case and there's only one word, so we can't be sure )) { title = ZU.capitalizeTitle(title, true); } newItem.publicationTitle = title; } else if (newItem.journalAbbreviation) { newItem.publicationTitle = newItem.journalAbbreviation; } // (do we want this?) if (newItem.publicationTitle) { newItem.publicationTitle = ZU.capitalizeTitle(newItem.publicationTitle); } var journalIssue = ZU.xpath(journal, 'JournalIssue')[0]; if (journalIssue) { newItem.volume = ZU.xpathText(journalIssue, 'Volume'); newItem.issue = ZU.xpathText(journalIssue, 'Issue'); var pubDate = ZU.xpath(journalIssue, 'PubDate')[0]; if (pubDate) { // try to get the date var day = ZU.xpathText(pubDate, 'Day'); var month = ZU.xpathText(pubDate, 'Month'); var year = ZU.xpathText(pubDate, 'Year'); if (day) { // month appears in two different formats: // 1. numeric, e.g. "07", see 4th test if (month && /\d+/.test(month)) { newItem.date = ZU.strToISO(year + "-" + month + "-" + day); } // 2. English acronym, e.g. "Aug", see 3rd test else { newItem.date = ZU.strToISO(month + " " + day + ", " + year); } } else if (month) { newItem.date = ZU.strToISO(month + "/" + year); } else if (year) { newItem.date = year; } else { newItem.date = ZU.xpathText(pubDate, 'MedlineDate'); } } } } var authorLists = ZU.xpath(article, 'AuthorList'); processAuthors(newItem, authorLists); newItem.language = ZU.xpathText(article, 'Language'); var keywords = ZU.xpath(citation, 'MeshHeadingList/MeshHeading'); for (let j = 0, m = keywords.length; j < m; j++) { newItem.tags.push(ZU.xpathText(keywords[j], 'DescriptorName')); } // OT Terms var otherKeywords = ZU.xpath(citation, 'KeywordList/Keyword'); for (let j = 0, m = otherKeywords.length; j < m; j++) { newItem.tags.push(otherKeywords[j].textContent); } var abstractSections = ZU.xpath(article, 'Abstract/AbstractText'); var abstractNote = []; for (let j = 0, m = abstractSections.length; j < m; j++) { var abstractSection = abstractSections[j]; var paragraph = abstractSection.textContent.trim(); if (paragraph) paragraph += '\n'; var label = abstractSection.hasAttribute("Label") && abstractSection.getAttribute("Label"); if (label && label != "UNLABELLED") { paragraph = label + ": " + paragraph; } abstractNote.push(paragraph); } newItem.abstractNote = abstractNote.join(''); newItem.DOI = ZU.xpathText(articles[i], 'PubmedData/ArticleIdList/ArticleId[@IdType="doi"]'); var PMID = ZU.xpathText(citation, 'PMID'); var PMCID = ZU.xpathText(articles[i], 'PubmedData/ArticleIdList/ArticleId[@IdType="pmc"]'); if (PMID) { newItem.extra = "PMID: " + PMID; // this is a catalog, so we should store links as attachments newItem.attachments.push({ title: "PubMed entry", url: "http://www.ncbi.nlm.nih.gov/pubmed/" + PMID, mimeType: "text/html", snapshot: false }); } if (PMCID) { newItem.extra = (newItem.extra ? newItem.extra + "\n" : "") + "PMCID: " + PMCID; } newItem.complete(); } // handle books and chapters var books = ZU.xpath(doc, '/PubmedArticleSet/PubmedBookArticle'); for (let i = 0, n = books.length; i < n; i++) { let citation = ZU.xpath(books[i], 'BookDocument')[0]; // check if this is a section var sectionTitle = ZU.xpathText(citation, 'ArticleTitle'); var isBookSection = !!sectionTitle; // eslint-disable-next-line var newItem = new Zotero.Item(isBookSection ? 'bookSection' : 'book'); if (isBookSection) { newItem.title = sectionTitle; } var book = ZU.xpath(citation, 'Book')[0]; // title let title = ZU.xpathText(book, 'BookTitle'); if (title) { if (title.charAt(title.length - 1) == ".") { title = title.substring(0, title.length - 1); } if (isBookSection) { newItem.publicationTitle = title; } else { newItem.title = title; } } // date // should only need year for books newItem.date = ZU.xpathText(book, 'PubDate/Year'); // edition newItem.edition = ZU.xpathText(book, 'Edition'); // series newItem.series = ZU.xpathText(book, 'CollectionTitle'); // volume newItem.volume = ZU.xpathText(book, 'Volume'); // place newItem.place = ZU.xpathText(book, 'Publisher/PublisherLocation'); // publisher newItem.publisher = ZU.xpathText(book, 'Publisher/PublisherName'); // chapter authors if (isBookSection) { let authorsLists = ZU.xpath(citation, 'AuthorList'); processAuthors(newItem, authorsLists); } // book creators let authorsLists = ZU.xpath(book, 'AuthorList'); processAuthors(newItem, authorsLists); // language newItem.language = ZU.xpathText(citation, 'Language'); // abstractNote newItem.abstractNote = ZU.xpathText(citation, 'Abstract/AbstractText'); // rights newItem.rights = ZU.xpathText(citation, 'Abstract/CopyrightInformation'); // seriesNumber, numPages, numberOfVolumes // not available // ISBN newItem.ISBN = ZU.xpathText(book, 'Isbn'); let PMID = ZU.xpathText(citation, 'PMID'); if (PMID) { newItem.extra = "PMID: " + PMID; // this is a catalog, so we should store links as attachments newItem.attachments.push({ title: "PubMed entry", url: "http://www.ncbi.nlm.nih.gov/pubmed/" + PMID, mimeType: "text/html", snapshot: false }); } newItem.callNumber = ZU.xpathText(citation, 'ArticleIdList/ArticleId[@IdType="bookaccession"]'); // attach link to the bookshelf page if (newItem.callNumber) { var url = "http://www.ncbi.nlm.nih.gov/books/" + newItem.callNumber + "/"; if (PMID) { // books with PMIDs appear to be hosted at NCBI newItem.url = url; // book sections have printable views, which can stand in for full text PDFs if (newItem.itemType == 'bookSection') { newItem.attachments.push({ title: "Printable HTML", url: 'http://www.ncbi.nlm.nih.gov/books/' + newItem.callNumber + '/?report=printable', mimeType: 'text/html', snapshot: true }); } } else { // currently this should not trigger, since we only import books with PMIDs newItem.attachments.push({ title: "NCBI Bookshelf entry", url: "http://www.ncbi.nlm.nih.gov/books/" + newItem.callNumber + "/", mimeType: "text/html", snapshot: false }); } } newItem.complete(); } } /** BEGIN TEST CASES **/ var testCases = [ { "type": "import", "input": "\n\n\n\n \n 18157122\n \n 2008\n 01\n 18\n \n \n 2008\n 02\n 08\n \n \n 2014\n 07\n 25\n \n
\n \n 1552-4469\n \n 4\n 2\n \n 2008\n Feb\n \n \n Nature chemical biology\n Nat. Chem. Biol.\n \n High-content single-cell drug screening with phosphospecific flow cytometry.\n \n 132-42\n \n \n Drug screening is often limited to cell-free assays involving purified enzymes, but it is arguably best applied against systems that represent disease states or complex physiological cellular networks. Here, we describe a high-content, cell-based drug discovery platform based on phosphospecific flow cytometry, or phosphoflow, that enabled screening for inhibitors against multiple endogenous kinase signaling pathways in heterogeneous primary cell populations at the single-cell level. From a library of small-molecule natural products, we identified pathway-selective inhibitors of Jak-Stat and MAP kinase signaling. Dose-response experiments in primary cells confirmed pathway selectivity, but importantly also revealed differential inhibition of cell types and new druggability trends across multiple compounds. Lead compound selectivity was confirmed in vivo in mice. Phosphoflow therefore provides a unique platform that can be applied throughout the drug discovery process, from early compound screening to in vivo testing and clinical monitoring of drug efficacy.\n \n \n \n Krutzik\n Peter O\n PO\n \n Department of Microbiology and Immunology, Baxter Laboratory in Genetic Pharmacology, Stanford University, 269 Campus Drive, Stanford, California 94305, USA.\n \n \n \n Crane\n Janelle M\n JM\n \n \n Clutter\n Matthew R\n MR\n \n \n Nolan\n Garry P\n GP\n \n \n eng\n \n \n PubChem-Substance\n \n 46391334\n 46391335\n 46391336\n 46391337\n 46391338\n 46391339\n 46391340\n 46391341\n 46391342\n 46391343\n 46391344\n 46391345\n 46391346\n 46391347\n 46391348\n 46391349\n 46391350\n 46391351\n 46391352\n 46391353\n 46391354\n 46391355\n 46391356\n 46391357\n \n \n \n \n \n AI35304\n AI\n NIAID NIH HHS\n United States\n \n \n N01-HV-28183\n HV\n NHLBI NIH HHS\n United States\n \n \n T32 AI007290\n AI\n NIAID NIH HHS\n United States\n \n \n \n Journal Article\n Research Support, N.I.H., Extramural\n Research Support, Non-U.S. Gov't\n \n \n 2007\n 12\n 23\n \n
\n \n United States\n Nat Chem Biol\n 101231976\n 1552-4450\n \n \n \n 0\n STAT Transcription Factors\n \n \n 27YLU75U4W\n Phosphorus\n \n \n EC 2.7.10.2\n Janus Kinases\n \n \n EC 2.7.11.24\n Mitogen-Activated Protein Kinases\n \n \n IM\n \n \n Animals\n \n \n Cell Line, Tumor\n \n \n Drug Evaluation, Preclinical\n \n \n Flow Cytometry\n methods\n \n \n Humans\n \n \n Janus Kinases\n metabolism\n \n \n Mice\n \n \n Mice, Inbred BALB C\n \n \n Mitogen-Activated Protein Kinases\n metabolism\n \n \n Phosphorus\n analysis\n \n \n STAT Transcription Factors\n metabolism\n \n \n Sensitivity and Specificity\n \n \n Signal Transduction\n \n \n
\n \n \n \n 2007\n 6\n 15\n \n \n 2007\n 10\n 30\n \n \n 2007\n 12\n 23\n \n \n 2007\n 12\n 25\n 9\n 0\n \n \n 2008\n 2\n 9\n 9\n 0\n \n \n 2007\n 12\n 25\n 9\n 0\n \n \n ppublish\n \n nchembio.2007.59\n 10.1038/nchembio.2007.59\n 18157122\n \n \n
\n\n \n 18157123\n \n 2008\n 01\n 18\n \n \n 2008\n 02\n 08\n \n \n 2013\n 11\n 21\n \n
\n \n 1552-4469\n \n 4\n 2\n \n 2008\n Feb\n \n \n Nature chemical biology\n Nat. Chem. Biol.\n \n Site selectivity of platinum anticancer therapeutics.\n \n 110-2\n \n \n X-ray crystallographic and biochemical investigation of the reaction of cisplatin and oxaliplatin with nucleosome core particle and naked DNA reveals that histone octamer association can modulate DNA platination. Adduct formation also occurs at specific histone methionine residues, which could serve as a nuclear platinum reservoir influencing adduct transfer to DNA. Our findings suggest that the nucleosome center may provide a favorable target for the design of improved platinum anticancer drugs.\n \n \n \n Wu\n Bin\n B\n \n Division of Structural and Computational Biology, School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, Singapore.\n \n \n \n Dröge\n Peter\n P\n \n \n Davey\n Curt A\n CA\n \n \n eng\n \n \n PubChem-Substance\n \n 46095911\n 46095912\n \n \n \n \n Journal Article\n Research Support, Non-U.S. Gov't\n \n \n 2007\n 12\n 23\n \n
\n \n United States\n Nat Chem Biol\n 101231976\n 1552-4450\n \n \n \n 0\n Antineoplastic Agents\n \n \n 0\n DNA Adducts\n \n \n 0\n Histones\n \n \n 0\n Nucleosomes\n \n \n 49DFR088MY\n Platinum\n \n \n IM\n \n \n Amino Acid Sequence\n \n \n Antineoplastic Agents\n chemistry\n \n \n Base Sequence\n \n \n Crystallography, X-Ray\n \n \n DNA Adducts\n chemistry\n \n \n Histones\n chemistry\n metabolism\n \n \n Models, Molecular\n \n \n Molecular Sequence Data\n \n \n Nucleosomes\n chemistry\n metabolism\n \n \n Platinum\n chemistry\n \n \n Protein Structure, Tertiary\n \n \n Sensitivity and Specificity\n \n \n
\n \n \n \n 2007\n 6\n 07\n \n \n 2007\n 10\n 26\n \n \n 2007\n 12\n 23\n \n \n 2007\n 12\n 25\n 9\n 0\n \n \n 2008\n 2\n 9\n 9\n 0\n \n \n 2007\n 12\n 25\n 9\n 0\n \n \n ppublish\n \n nchembio.2007.58\n 10.1038/nchembio.2007.58\n 18157123\n \n \n
\n\n
\n", "items": [ { "itemType": "journalArticle", "title": "High-content single-cell drug screening with phosphospecific flow cytometry", "creators": [ { "firstName": "Peter O.", "lastName": "Krutzik", "creatorType": "author" }, { "firstName": "Janelle M.", "lastName": "Crane", "creatorType": "author" }, { "firstName": "Matthew R.", "lastName": "Clutter", "creatorType": "author" }, { "firstName": "Garry P.", "lastName": "Nolan", "creatorType": "author" } ], "date": "2008-02", "DOI": "10.1038/nchembio.2007.59", "ISSN": "1552-4469", "abstractNote": "Drug screening is often limited to cell-free assays involving purified enzymes, but it is arguably best applied against systems that represent disease states or complex physiological cellular networks. Here, we describe a high-content, cell-based drug discovery platform based on phosphospecific flow cytometry, or phosphoflow, that enabled screening for inhibitors against multiple endogenous kinase signaling pathways in heterogeneous primary cell populations at the single-cell level. From a library of small-molecule natural products, we identified pathway-selective inhibitors of Jak-Stat and MAP kinase signaling. Dose-response experiments in primary cells confirmed pathway selectivity, but importantly also revealed differential inhibition of cell types and new druggability trends across multiple compounds. Lead compound selectivity was confirmed in vivo in mice. Phosphoflow therefore provides a unique platform that can be applied throughout the drug discovery process, from early compound screening to in vivo testing and clinical monitoring of drug efficacy.", "extra": "PMID: 18157122", "issue": "2", "journalAbbreviation": "Nat. Chem. Biol.", "language": "eng", "pages": "132-142", "publicationTitle": "Nature Chemical Biology", "volume": "4", "attachments": [ { "title": "PubMed entry", "mimeType": "text/html", "snapshot": false } ], "tags": [ { "tag": "Animals" }, { "tag": "Cell Line, Tumor" }, { "tag": "Drug Evaluation, Preclinical" }, { "tag": "Flow Cytometry" }, { "tag": "Humans" }, { "tag": "Janus Kinases" }, { "tag": "Mice" }, { "tag": "Mice, Inbred BALB C" }, { "tag": "Mitogen-Activated Protein Kinases" }, { "tag": "Phosphorus" }, { "tag": "STAT Transcription Factors" }, { "tag": "Sensitivity and Specificity" }, { "tag": "Signal Transduction" } ], "notes": [], "seeAlso": [] }, { "itemType": "journalArticle", "title": "Site selectivity of platinum anticancer therapeutics", "creators": [ { "firstName": "Bin", "lastName": "Wu", "creatorType": "author" }, { "firstName": "Peter", "lastName": "Dröge", "creatorType": "author" }, { "firstName": "Curt A.", "lastName": "Davey", "creatorType": "author" } ], "date": "2008-02", "DOI": "10.1038/nchembio.2007.58", "ISSN": "1552-4469", "abstractNote": "X-ray crystallographic and biochemical investigation of the reaction of cisplatin and oxaliplatin with nucleosome core particle and naked DNA reveals that histone octamer association can modulate DNA platination. Adduct formation also occurs at specific histone methionine residues, which could serve as a nuclear platinum reservoir influencing adduct transfer to DNA. Our findings suggest that the nucleosome center may provide a favorable target for the design of improved platinum anticancer drugs.", "extra": "PMID: 18157123", "issue": "2", "journalAbbreviation": "Nat. Chem. Biol.", "language": "eng", "pages": "110-112", "publicationTitle": "Nature Chemical Biology", "volume": "4", "attachments": [ { "title": "PubMed entry", "mimeType": "text/html", "snapshot": false } ], "tags": [ { "tag": "Amino Acid Sequence" }, { "tag": "Antineoplastic Agents" }, { "tag": "Base Sequence" }, { "tag": "Crystallography, X-Ray" }, { "tag": "DNA Adducts" }, { "tag": "Histones" }, { "tag": "Models, Molecular" }, { "tag": "Molecular Sequence Data" }, { "tag": "Nucleosomes" }, { "tag": "Platinum" }, { "tag": "Protein Structure, Tertiary" }, { "tag": "Sensitivity and Specificity" } ], "notes": [], "seeAlso": [] } ] }, { "type": "import", "input": "\n\n\n\n \n 20821847\n \n NBK22\n \n \n \n BIOS Scientific Publishers\n Oxford\n \n Endocrinology: An Integrated Approach\n \n 2001\n \n \n \n Nussey\n Stephen\n S\n \n \n Whitehead\n Saffron\n S\n \n \n 1859962521\n \n eng\n \n Endocrinology has been written to meet the requirements of today's trainee doctors and the demands of an increasing number of degree courses in health and biomedical sciences, and allied subjects. It is a truly integrated text using large numbers of real clinical cases to introduce the basic biochemistry, physiology and pathophysiology underlying endocrine disorders and also the principles of clinical diagnosis and treatment. The increasing importance of the molecular and genetic aspects of endocrinology in relation to clinical medicine is explained.\n Copyright © 2001, BIOS Scientific Publishers Limited\n \n \n
\n Preface\n
\n
\n Chapter 1\n Principles of endocrinology\n
\n
\n Chapter 2\n The endocrine pancreas\n
\n
\n Chapter 3\n The thyroid gland\n
\n
\n Chapter 4\n The adrenal gland\n
\n
\n Chapter 5\n The parathyroid glands and vitamin D\n
\n
\n Chapter 6\n The gonad\n
\n
\n Chapter 7\n The pituitary gland\n
\n
\n Chapter 8\n Cardiovascular and renal endocrinology\n
\n
\n
\n \n \n \n 2010\n 9\n 8\n 6\n 0\n \n \n 2010\n 9\n 8\n 6\n 0\n \n \n 2010\n 9\n 8\n 6\n 0\n \n \n ppublish\n \n 20821847\n \n \n
\n\n
\n", "items": [ { "itemType": "book", "title": "Endocrinology: An Integrated Approach", "creators": [ { "firstName": "Stephen", "lastName": "Nussey", "creatorType": "author" }, { "firstName": "Saffron", "lastName": "Whitehead", "creatorType": "author" } ], "date": "2001", "ISBN": "1859962521", "abstractNote": "Endocrinology has been written to meet the requirements of today's trainee doctors and the demands of an increasing number of degree courses in health and biomedical sciences, and allied subjects. It is a truly integrated text using large numbers of real clinical cases to introduce the basic biochemistry, physiology and pathophysiology underlying endocrine disorders and also the principles of clinical diagnosis and treatment. The increasing importance of the molecular and genetic aspects of endocrinology in relation to clinical medicine is explained.", "callNumber": "NBK22", "extra": "PMID: 20821847", "language": "eng", "place": "Oxford", "publisher": "BIOS Scientific Publishers", "rights": "Copyright © 2001, BIOS Scientific Publishers Limited", "url": "http://www.ncbi.nlm.nih.gov/books/NBK22/", "attachments": [ { "title": "PubMed entry", "mimeType": "text/html", "snapshot": false } ], "tags": [], "notes": [], "seeAlso": [] } ] }, { "type": "import", "input": "\n\n\n\n\n \n 26074225\n \n 2015\n 07\n 20\n \n
\n \n 1525-3198\n \n 98\n 8\n \n 2015\n Aug\n \n \n Journal of dairy science\n J. Dairy Sci.\n \n Evaluation of testing strategies to identify infected animals at a single round of testing within dairy herds known to be infected with Mycobacterium avium ssp. paratuberculosis.\n \n 5194-210\n \n 10.3168/jds.2014-8211\n S0022-0302(15)00395-1\n \n As part of a broader control strategy within herds known to be infected with Mycobacterium avium ssp. paratuberculosis (MAP), individual animal testing is generally conducted to identify infected animals for action, usually culling. Opportunities are now available to quantitatively compare different testing strategies (combinations of tests) in known infected herds. This study evaluates the effectiveness, cost, and cost-effectiveness of different testing strategies to identify infected animals at a single round of testing within dairy herds known to be MAP infected. A model was developed, taking account of both within-herd infection dynamics and test performance, to simulate the use of different tests at a single round of testing in a known infected herd. Model inputs included the number of animals at different stages of infection, the sensitivity and specificity of each test, and the costs of testing and culling. Testing strategies included either milk or serum ELISA alone or with fecal culture in series. Model outputs included effectiveness (detection fraction, the proportion of truly infected animals in the herd that are successfully detected by the testing strategy), cost, and cost-effectiveness (testing cost per true positive detected, total cost per true positive detected). Several assumptions were made: MAP was introduced with a single animal and no management interventions were implemented to limit within-herd transmission of MAP before this test. In medium herds, between 7 and 26% of infected animals are detected at a single round of testing, the former using the milk ELISA and fecal culture in series 5 yr after MAP introduction and the latter using fecal culture alone 15 yr after MAP introduction. The combined costs of testing and culling at a single round of testing increases with time since introduction of MAP infection, with culling costs being much greater than testing costs. The cost-effectiveness of testing varied by testing strategy. It was also greater at 5 yr, compared with 10 or 15 yr, since MAP introduction, highlighting the importance of early detection. Future work is needed to evaluate these testing strategies in subsequent rounds of testing as well as accounting for different herd dynamics and different levels of herd biocontainment.\n Copyright © 2015 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.\n \n \n \n More\n S J\n SJ\n \n Centre for Veterinary Epidemiology and Risk Analysis, UCD School of Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Ireland. Electronic address: simon.more@ucd.ie.\n \n \n \n Cameron\n A R\n AR\n \n AusVet Animal Health Services Pty Ltd., 69001 Lyon, France.\n \n \n \n Strain\n S\n S\n \n Animal Health & Welfare Northern Ireland, Dungannon BT71 7DX, Northern Ireland.\n \n \n \n Cashman\n W\n W\n \n Riverstown Cross, Glanmire, Co. Cork, Ireland.\n \n \n \n Ezanno\n P\n P\n \n INRA, Oniris, LUNAM Université, UMR1300 Biologie, Epidémiologie et Analyse de Risque en Santé Animale, CS 40706, F-44307 Nantes, France.\n \n \n \n Kenny\n K\n K\n \n Central Veterinary Research Laboratory, Department of Agriculture, Food and the Marine, Backweston, Cellbridge, Co. Kildare, Ireland.\n \n \n \n Fourichon\n C\n C\n \n INRA, Oniris, LUNAM Université, UMR1300 Biologie, Epidémiologie et Analyse de Risque en Santé Animale, CS 40706, F-44307 Nantes, France.\n \n \n \n Graham\n D\n D\n \n Animal Health Ireland, Main Street, Carrick-on-Shannon, Co. Leitrim, Ireland.\n \n \n \n eng\n \n Journal Article\n Research Support, Non-U.S. Gov't\n \n \n 2015\n 07\n 07\n \n
\n \n United States\n J Dairy Sci\n 2985126R\n 0022-0302\n \n IM\n \n Johne’s disease\n control\n evaluation\n infected herd\n testing strategies\n \n
\n \n \n \n 2014\n 4\n 7\n \n \n 2015\n 4\n 24\n \n \n 2015\n 7\n 7\n \n \n 2015\n 6\n 16\n 6\n 0\n \n \n 2015\n 6\n 16\n 6\n 0\n \n \n 2015\n 6\n 16\n 6\n 0\n \n \n ppublish\n \n 26074225\n S0022-0302(15)00395-1\n 10.3168/jds.2014-8211\n \n \n
\n\n\n\n \n 26166904\n \n 2015\n 7\n 13\n \n \n 2015\n 7\n 19\n \n
\n \n 0035-9254\n \n 64\n 4\n \n 2015\n Aug\n 1\n \n \n Journal of the Royal Statistical Society. Series C, Applied statistics\n J R Stat Soc Ser C Appl Stat\n \n Optimal retesting configurations for hierarchical group testing.\n \n 693-710\n \n \n Hierarchical group testing is widely used to test individuals for diseases. This testing procedure works by first amalgamating individual specimens into groups for testing. Groups testing negatively have their members declared negative. Groups testing positively are subsequently divided into smaller subgroups and are then retested to search for positive individuals. In our paper, we propose a new class of informative retesting procedures for hierarchical group testing that acknowledges heterogeneity among individuals. These procedures identify the optimal number of groups and their sizes at each testing stage in order to minimize the expected number of tests. We apply our proposals in two settings: 1) HIV testing programs that currently use three-stage hierarchical testing and 2) chlamydia and gonorrhea screening practices that currently use individual testing. For both applications, we show that substantial savings can be realized by our new procedures.\n \n \n \n Black\n Michael S\n MS\n \n Department of Mathematics, University of Wisconsin-Platteville, Platteville, WI 53818, USA, blackmi@uwplatt.edu.\n \n \n \n Bilder\n Christopher R\n CR\n \n Department of Statistics, University of Nebraska-Lincoln, Lincoln, NE 68583, USA.\n \n \n \n Tebbs\n Joshua M\n JM\n \n Department of Statistics, University of South Carolina, Columbia, SC 29208, USA, tebbs@stat.sc.edu.\n \n \n \n ENG\n \n \n R01 AI067373\n AI\n NIAID NIH HHS\n United States\n \n \n \n JOURNAL ARTICLE\n \n
\n \n J R Stat Soc Ser C Appl Stat\n 101086541\n 0035-9254\n \n \n Classification\n HIV\n Infertility Prevention Project\n Informative retesting\n Pooled testing\n Retesting\n \n
\n \n \n \n 2015\n 7\n 14\n 6\n 0\n \n \n 2015\n 7\n 15\n 6\n 0\n \n \n 2015\n 7\n 15\n 6\n 0\n \n \n 2016\n 8\n 1\n 0\n 0\n \n \n ppublish\n \n 10.1111/rssc.12097\n 26166904\n PMC4495770\n NIHMS641826\n \n \n \n
\n\n
", "items": [ { "itemType": "journalArticle", "title": "Evaluation of testing strategies to identify infected animals at a single round of testing within dairy herds known to be infected with Mycobacterium avium ssp. paratuberculosis", "creators": [ { "firstName": "S. J.", "lastName": "More", "creatorType": "author" }, { "firstName": "A. R.", "lastName": "Cameron", "creatorType": "author" }, { "firstName": "S.", "lastName": "Strain", "creatorType": "author" }, { "firstName": "W.", "lastName": "Cashman", "creatorType": "author" }, { "firstName": "P.", "lastName": "Ezanno", "creatorType": "author" }, { "firstName": "K.", "lastName": "Kenny", "creatorType": "author" }, { "firstName": "C.", "lastName": "Fourichon", "creatorType": "author" }, { "firstName": "D.", "lastName": "Graham", "creatorType": "author" } ], "date": "2015-08", "DOI": "10.3168/jds.2014-8211", "ISSN": "1525-3198", "abstractNote": "As part of a broader control strategy within herds known to be infected with Mycobacterium avium ssp. paratuberculosis (MAP), individual animal testing is generally conducted to identify infected animals for action, usually culling. Opportunities are now available to quantitatively compare different testing strategies (combinations of tests) in known infected herds. This study evaluates the effectiveness, cost, and cost-effectiveness of different testing strategies to identify infected animals at a single round of testing within dairy herds known to be MAP infected. A model was developed, taking account of both within-herd infection dynamics and test performance, to simulate the use of different tests at a single round of testing in a known infected herd. Model inputs included the number of animals at different stages of infection, the sensitivity and specificity of each test, and the costs of testing and culling. Testing strategies included either milk or serum ELISA alone or with fecal culture in series. Model outputs included effectiveness (detection fraction, the proportion of truly infected animals in the herd that are successfully detected by the testing strategy), cost, and cost-effectiveness (testing cost per true positive detected, total cost per true positive detected). Several assumptions were made: MAP was introduced with a single animal and no management interventions were implemented to limit within-herd transmission of MAP before this test. In medium herds, between 7 and 26% of infected animals are detected at a single round of testing, the former using the milk ELISA and fecal culture in series 5 yr after MAP introduction and the latter using fecal culture alone 15 yr after MAP introduction. The combined costs of testing and culling at a single round of testing increases with time since introduction of MAP infection, with culling costs being much greater than testing costs. The cost-effectiveness of testing varied by testing strategy. It was also greater at 5 yr, compared with 10 or 15 yr, since MAP introduction, highlighting the importance of early detection. Future work is needed to evaluate these testing strategies in subsequent rounds of testing as well as accounting for different herd dynamics and different levels of herd biocontainment.", "extra": "PMID: 26074225", "issue": "8", "journalAbbreviation": "J. Dairy Sci.", "language": "eng", "pages": "5194-5210", "publicationTitle": "Journal of Dairy Science", "volume": "98", "attachments": [ { "title": "PubMed entry", "mimeType": "text/html", "snapshot": false } ], "tags": [ { "tag": "Johne’s disease" }, { "tag": "control" }, { "tag": "evaluation" }, { "tag": "infected herd" }, { "tag": "testing strategies" } ], "notes": [], "seeAlso": [] }, { "itemType": "journalArticle", "title": "Optimal retesting configurations for hierarchical group testing", "creators": [ { "firstName": "Michael S.", "lastName": "Black", "creatorType": "author" }, { "firstName": "Christopher R.", "lastName": "Bilder", "creatorType": "author" }, { "firstName": "Joshua M.", "lastName": "Tebbs", "creatorType": "author" } ], "date": "2015-08-01", "DOI": "10.1111/rssc.12097", "ISSN": "0035-9254", "abstractNote": "Hierarchical group testing is widely used to test individuals for diseases. This testing procedure works by first amalgamating individual specimens into groups for testing. Groups testing negatively have their members declared negative. Groups testing positively are subsequently divided into smaller subgroups and are then retested to search for positive individuals. In our paper, we propose a new class of informative retesting procedures for hierarchical group testing that acknowledges heterogeneity among individuals. These procedures identify the optimal number of groups and their sizes at each testing stage in order to minimize the expected number of tests. We apply our proposals in two settings: 1) HIV testing programs that currently use three-stage hierarchical testing and 2) chlamydia and gonorrhea screening practices that currently use individual testing. For both applications, we show that substantial savings can be realized by our new procedures.", "extra": "PMID: 26166904\nPMCID: PMC4495770", "issue": "4", "journalAbbreviation": "J R Stat Soc Ser C Appl Stat", "language": "ENG", "pages": "693-710", "publicationTitle": "Journal of the Royal Statistical Society. Series C, Applied Statistics", "volume": "64", "attachments": [ { "title": "PubMed entry", "mimeType": "text/html", "snapshot": false } ], "tags": [ { "tag": "Classification" }, { "tag": "HIV" }, { "tag": "Infertility Prevention Project" }, { "tag": "Informative retesting" }, { "tag": "Pooled testing" }, { "tag": "Retesting" } ], "notes": [], "seeAlso": [] } ] }, { "type": "import", "input": "\n \n \n \n \n 20729678\n \n 2010\n 12\n 21\n \n \n 2019\n 12\n 10\n \n
\n \n 1538-9855\n \n 35\n 5\n \n 2010 Sep-Oct\n \n \n Nurse educator\n \n Zotero: harnessing the power of a personal bibliographic manager.\n \n 205-7\n \n 10.1097/NNE.0b013e3181ed81e4\n \n Zotero is a powerful free personal bibliographic manager (PBM) for writers. Use of a PBM allows the writer to focus on content, rather than the tedious details of formatting citations and references. Zotero 2.0 (http://www.zotero.org) has new features including the ability to synchronize citations with the off-site Zotero server and the ability to collaborate and share with others. An overview on how to use the software and discussion about the strengths and limitations are included.\n \n \n \n Coar\n Jaekea T\n JT\n \n School of Nursing, Georgia College & State University, Milledgeville, Georgia 61061, USA.\n \n \n \n Sewell\n Jeanne P\n JP\n \n \n eng\n \n Journal Article\n \n
\n \n United States\n Nurse Educ\n 7701902\n 0363-3624\n \n N\n \n \n Bibliographies as Topic\n \n \n Database Management Systems\n \n \n Humans\n \n \n
\n \n \n \n 2010\n 8\n 24\n 6\n 0\n \n \n 2010\n 8\n 24\n 6\n 0\n \n \n 2010\n 12\n 22\n 6\n 0\n \n \n ppublish\n \n 20729678\n 10.1097/NNE.0b013e3181ed81e4\n 00006223-201009000-00011\n \n \n
\n \n
", "items": [ { "itemType": "journalArticle", "title": "Zotero: harnessing the power of a personal bibliographic manager", "creators": [ { "firstName": "Jaekea T.", "lastName": "Coar", "creatorType": "author" }, { "firstName": "Jeanne P.", "lastName": "Sewell", "creatorType": "author" } ], "date": "2010 Sep-Oct", "DOI": "10.1097/NNE.0b013e3181ed81e4", "ISSN": "1538-9855", "abstractNote": "Zotero is a powerful free personal bibliographic manager (PBM) for writers. Use of a PBM allows the writer to focus on content, rather than the tedious details of formatting citations and references. Zotero 2.0 (http://www.zotero.org) has new features including the ability to synchronize citations with the off-site Zotero server and the ability to collaborate and share with others. An overview on how to use the software and discussion about the strengths and limitations are included.", "extra": "PMID: 20729678", "issue": "5", "journalAbbreviation": "Nurse Educ", "language": "eng", "pages": "205-207", "publicationTitle": "Nurse Educator", "volume": "35", "attachments": [ { "title": "PubMed entry", "mimeType": "text/html", "snapshot": false } ], "tags": [ { "tag": "Bibliographies as Topic" }, { "tag": "Database Management Systems" }, { "tag": "Humans" } ], "notes": [], "seeAlso": [] } ] }, { "type": "import", "input": "\n \n \n \n \n 30133126\n \n 2019\n 01\n 29\n \n \n 2019\n 01\n 29\n \n
\n \n 1601-183X\n \n 17\n 8\n \n 2018\n 11\n \n \n Genes, brain, and behavior\n Genes Brain Behav\n \n Neph2/Kirrel3 regulates sensory input, motor coordination, and home-cage activity in rodents.\n \n e12516\n \n 10.1111/gbb.12516\n \n Adhesion molecules of the immunoglobulin superfamily (IgSF) are essential for neuronal synapse development across evolution and control various aspects of synapse formation and maturation. Neph2, also known as Kirrel3, is an IgSF adhesion molecule implicated in synapse formation, synaptic transmission and ultrastructure. In humans, defects in the NEPH2 gene have been associated with neurodevelopmental disorders such as Jacobsen syndrome, intellectual disability, and autism-spectrum disorders. However, the precise role in development and function of the nervous system is still unclear. Here, we present the histomorphological and phenotypical analysis of a constitutive Neph2-knockout mouse line. Knockout mice display defects in auditory sensory processing, motor skills, and hyperactivity in the home-cage analysis. Olfactory, memory and metabolic testing did not differ from controls. Despite the wide-spread expression of Neph2 in various brain areas, no gross anatomic defects could be observed. Neph2 protein could be located at the cerebellar pinceaux. It interacted with the pinceau core component neurofascin and other synaptic proteins thus suggesting a possible role in cerebellar synapse formation and circuit assembly. Our results suggest that Neph2/Kirrel3 acts on the synaptic ultrastructural level and neuronal wiring rather than on ontogenetic events affecting macroscopic structure. Neph2-knockout mice may provide a valuable rodent model for research on autism spectrum diseases and neurodevelopmental disorders.\n © 2018 John Wiley & Sons Ltd and International Behavioural and Neural Genetics Society.\n \n \n \n Völker\n Linus A\n LA\n 0000-0002-4461-6128\n \n Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.\n \n \n \n Maar\n Barbara A\n BA\n \n Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.\n \n \n \n Pulido Guevara\n Barbara A\n BA\n \n Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.\n \n \n \n Bilkei-Gorzo\n Andras\n A\n \n Institute of Molecular Psychiatry, Medical Faculty of the University of Bonn, Bonn, Germany.\n \n \n \n Zimmer\n Andreas\n A\n \n Institute of Molecular Psychiatry, Medical Faculty of the University of Bonn, Bonn, Germany.\n \n \n \n Brönneke\n Hella\n H\n \n Mouse Phenotyping Core Facility, Cologne Excellence Cluster on Cellular Stress Responses (CECAD), 50931 Cologne, Germany.\n \n \n \n Dafinger\n Claudia\n C\n \n Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.\n \n \n \n Bertsch\n Sabine\n S\n \n Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.\n \n \n \n Wagener\n Jan-Robin\n JR\n \n Institute for Neuroanatomy, Universitätsmedizin Göttingen, Georg-August-University Göttingen, Göttingen, Germany.\n \n \n \n Schweizer\n Heiko\n H\n \n Renal Division, University Hospital Freiburg, Freiburg, Germany.\n \n \n \n Schermer\n Bernhard\n B\n \n Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.\n \n \n Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.\n \n \n Systems Biology of Ageing Cologne (Sybacol), University of Cologne, Cologne, Germany.\n \n \n \n Benzing\n Thomas\n T\n \n Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.\n \n \n Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.\n \n \n Systems Biology of Ageing Cologne (Sybacol), University of Cologne, Cologne, Germany.\n \n \n \n Hoehne\n Martin\n M\n \n Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.\n \n \n Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.\n \n \n Systems Biology of Ageing Cologne (Sybacol), University of Cologne, Cologne, Germany.\n \n \n \n eng\n \n Journal Article\n \n \n 2018\n 09\n 14\n \n
\n \n England\n Genes Brain Behav\n 101129617\n 1601-183X\n \n \n \n 0\n Carrier Proteins\n \n \n 0\n Immunoglobulins\n \n \n 0\n Kirrel3 protein, mouse\n \n \n 0\n Membrane Proteins\n \n \n IM\n \n \n Animals\n \n \n Carrier Proteins\n genetics\n \n \n Cell Adhesion\n physiology\n \n \n Immunoglobulins\n physiology\n \n \n Membrane Proteins\n genetics\n physiology\n \n \n Mice\n \n \n Mice, Knockout\n \n \n Neurogenesis\n \n \n Neurons\n metabolism\n \n \n Synapses\n metabolism\n \n \n \n Jacobsen syndrome\n Kirrel3\n Neph2\n attention-deficit hyperactivity disorder\n autism-spectrum disorder\n behavior\n cerebellum\n intellectual disability\n knockout\n neurodevelopmental disorders\n neurofascin\n olfaction\n phenotyping\n \n
\n \n \n \n 2018\n 04\n 07\n \n \n 2018\n 07\n 22\n \n \n 2018\n 08\n 17\n \n \n 2018\n 8\n 23\n 6\n 0\n \n \n 2019\n 1\n 30\n 6\n 0\n \n \n 2018\n 8\n 23\n 6\n 0\n \n \n ppublish\n \n 30133126\n 10.1111/gbb.12516\n \n \n
\n \n
", "items": [ { "itemType": "journalArticle", "title": "Neph2/Kirrel3 regulates sensory input, motor coordination, and home-cage activity in rodents", "creators": [ { "firstName": "Linus A.", "lastName": "Völker", "creatorType": "author" }, { "firstName": "Barbara A.", "lastName": "Maar", "creatorType": "author" }, { "firstName": "Barbara A.", "lastName": "Pulido Guevara", "creatorType": "author" }, { "firstName": "Andras", "lastName": "Bilkei-Gorzo", "creatorType": "author" }, { "firstName": "Andreas", "lastName": "Zimmer", "creatorType": "author" }, { "firstName": "Hella", "lastName": "Brönneke", "creatorType": "author" }, { "firstName": "Claudia", "lastName": "Dafinger", "creatorType": "author" }, { "firstName": "Sabine", "lastName": "Bertsch", "creatorType": "author" }, { "firstName": "Jan-Robin", "lastName": "Wagener", "creatorType": "author" }, { "firstName": "Heiko", "lastName": "Schweizer", "creatorType": "author" }, { "firstName": "Bernhard", "lastName": "Schermer", "creatorType": "author" }, { "firstName": "Thomas", "lastName": "Benzing", "creatorType": "author" }, { "firstName": "Martin", "lastName": "Hoehne", "creatorType": "author" } ], "date": "2018-11", "DOI": "10.1111/gbb.12516", "ISSN": "1601-183X", "abstractNote": "Adhesion molecules of the immunoglobulin superfamily (IgSF) are essential for neuronal synapse development across evolution and control various aspects of synapse formation and maturation. Neph2, also known as Kirrel3, is an IgSF adhesion molecule implicated in synapse formation, synaptic transmission and ultrastructure. In humans, defects in the NEPH2 gene have been associated with neurodevelopmental disorders such as Jacobsen syndrome, intellectual disability, and autism-spectrum disorders. However, the precise role in development and function of the nervous system is still unclear. Here, we present the histomorphological and phenotypical analysis of a constitutive Neph2-knockout mouse line. Knockout mice display defects in auditory sensory processing, motor skills, and hyperactivity in the home-cage analysis. Olfactory, memory and metabolic testing did not differ from controls. Despite the wide-spread expression of Neph2 in various brain areas, no gross anatomic defects could be observed. Neph2 protein could be located at the cerebellar pinceaux. It interacted with the pinceau core component neurofascin and other synaptic proteins thus suggesting a possible role in cerebellar synapse formation and circuit assembly. Our results suggest that Neph2/Kirrel3 acts on the synaptic ultrastructural level and neuronal wiring rather than on ontogenetic events affecting macroscopic structure. Neph2-knockout mice may provide a valuable rodent model for research on autism spectrum diseases and neurodevelopmental disorders.", "extra": "PMID: 30133126", "issue": "8", "journalAbbreviation": "Genes Brain Behav", "language": "eng", "pages": "e12516", "publicationTitle": "Genes, Brain, and Behavior", "volume": "17", "attachments": [ { "title": "PubMed entry", "mimeType": "text/html", "snapshot": false } ], "tags": [ { "tag": "Animals" }, { "tag": "Carrier Proteins" }, { "tag": "Cell Adhesion" }, { "tag": "Immunoglobulins" }, { "tag": "Jacobsen syndrome" }, { "tag": "Kirrel3" }, { "tag": "Membrane Proteins" }, { "tag": "Mice" }, { "tag": "Mice, Knockout" }, { "tag": "Neph2" }, { "tag": "Neurogenesis" }, { "tag": "Neurons" }, { "tag": "Synapses" }, { "tag": "attention-deficit hyperactivity disorder" }, { "tag": "autism-spectrum disorder" }, { "tag": "behavior" }, { "tag": "cerebellum" }, { "tag": "intellectual disability" }, { "tag": "knockout" }, { "tag": "neurodevelopmental disorders" }, { "tag": "neurofascin" }, { "tag": "olfaction" }, { "tag": "phenotyping" } ], "notes": [], "seeAlso": [] } ] }, { "type": "import", "input": "\n \n \n \n \n 30714901\n \n 2020\n 04\n 10\n \n \n 2020\n 04\n 10\n \n
\n \n 2050-084X\n \n 8\n \n 2019\n 02\n 04\n \n \n eLife\n Elife\n \n Stereotyped terminal axon branching of leg motor neurons mediated by IgSF proteins DIP-α and Dpr10.\n 10.7554/eLife.42692\n e42692\n \n For animals to perform coordinated movements requires the precise organization of neural circuits controlling motor function. Motor neurons (MNs), key components of these circuits, project their axons from the central nervous system and form precise terminal branching patterns at specific muscles. Focusing on the Drosophila leg neuromuscular system, we show that the stereotyped terminal branching of a subset of MNs is mediated by interacting transmembrane Ig superfamily proteins DIP-α and Dpr10, present in MNs and target muscles, respectively. The DIP-α/Dpr10 interaction is needed only after MN axons reach the vicinity of their muscle targets. Live imaging suggests that precise terminal branching patterns are gradually established by DIP-α/Dpr10-dependent interactions between fine axon filopodia and developing muscles. Further, different leg MNs depend on the DIP-α and Dpr10 interaction to varying degrees that correlate with the morphological complexity of the MNs and their muscle targets.\n © 2019, Venkatasubramanian et al.\n \n \n \n Venkatasubramanian\n Lalanti\n L\n 0000-0002-9280-8335\n \n Department of Biological Sciences, Columbia University, New York, United States.\n \n \n Department of Neuroscience, Mortimer B. Zuckerman Mind Brain Behavior Institute, New York, United States.\n \n \n \n Guo\n Zhenhao\n Z\n \n Department of Biological Sciences, Columbia University, New York, United States.\n \n \n \n Xu\n Shuwa\n S\n \n Department of Biological Chemistry, University of California, Los Angeles, Los Angeles, United States.\n \n \n \n Tan\n Liming\n L\n \n Department of Biological Chemistry, University of California, Los Angeles, Los Angeles, United States.\n \n \n \n Xiao\n Qi\n Q\n \n Department of Biological Chemistry, University of California, Los Angeles, Los Angeles, United States.\n \n \n \n Nagarkar-Jaiswal\n Sonal\n S\n \n Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States.\n \n \n \n Mann\n Richard S\n RS\n 0000-0002-4749-2765\n \n Department of Neuroscience, Mortimer B. Zuckerman Mind Brain Behavior Institute, New York, United States.\n \n \n Department of Biochemistry and Molecular Biophysics, Columbia University, New York, United States.\n \n \n \n eng\n \n \n U19NS104655\n NH\n NIH HHS\n United States\n \n \n R01NS070644\n NH\n NIH HHS\n United States\n \n \n R01 GM067858\n GM\n NIGMS NIH HHS\n United States\n \n \n R01 NS070644\n NS\n NINDS NIH HHS\n United States\n \n \n U19 NS104655\n NS\n NINDS NIH HHS\n United States\n \n \n \n Journal Article\n Research Support, N.I.H., Extramural\n \n \n 2019\n 02\n 04\n \n
\n \n England\n Elife\n 101579614\n 2050-084X\n \n \n \n 0\n DISCO Interacting Protein 1, Drosophila\n \n \n 0\n DSIP-immunoreactive peptide\n \n \n 0\n Drosophila Proteins\n \n \n 0\n Neuropeptides\n \n \n 0\n Transcription Factors\n \n \n IM\n \n \n Animals\n \n \n Axons\n metabolism\n \n \n Drosophila Proteins\n genetics\n metabolism\n \n \n Drosophila melanogaster\n genetics\n physiology\n \n \n Motor Neurons\n metabolism\n physiology\n \n \n Neurogenesis\n genetics\n \n \n Neurons, Efferent\n metabolism\n \n \n Neuropeptides\n genetics\n metabolism\n \n \n Transcription Factors\n genetics\n metabolism\n \n \n \n D. melanogaster\n DIP\n Dpr\n Ig domain proteins\n developmental biology\n leg development\n motor neuron\n neuroscience\n synapse formation\n \n LV, ZG, SX, LT, QX, SN, RM No competing interests declared\n
\n \n \n \n 2018\n 10\n 09\n \n \n 2019\n 01\n 31\n \n \n 2019\n 2\n 5\n 6\n 0\n \n \n 2020\n 4\n 11\n 6\n 0\n \n \n 2019\n 2\n 5\n 6\n 0\n \n \n epublish\n \n 30714901\n 10.7554/eLife.42692\n 42692\n PMC6391070\n \n \n \n Annu Rev Cell Dev Biol. 2015;31:669-98\n \n 26393773\n \n \n \n Elife. 2019 Feb 04;8:\n \n 30714906\n \n \n \n Cell. 2013 Jul 3;154(1):228-39\n \n 23827685\n \n \n \n Development. 2004 Dec;131(24):6041-51\n \n 15537687\n \n \n \n Genetics. 2000 Oct;156(2):723-31\n \n 11014819\n \n \n \n Neuron. 2005 Dec 22;48(6):949-64\n \n 16364899\n \n \n \n J Cachexia Sarcopenia Muscle. 2012 Mar;3(1):13-23\n \n 22450265\n \n \n \n Neuron. 1994 Aug;13(2):405-14\n \n 8060618\n \n \n \n Development. 2014 Dec;141(24):4667-80\n \n 25468936\n \n \n \n Adv Exp Med Biol. 2014;800:133-48\n \n 24243104\n \n \n \n PLoS One. 2006 Dec 27;1:e122\n \n 17205126\n \n \n \n J Neurosci. 1998 May 1;18(9):3297-313\n \n 9547238\n \n \n \n PLoS Genet. 2018 Aug 13;14(8):e1007560\n \n 30102700\n \n \n \n J Vis Exp. 2018 Oct 30;(140):\n \n 30451217\n \n \n \n Dev Biol. 2001 Jan 1;229(1):55-70\n \n 11133154\n \n \n \n Neuron. 2018 Feb 7;97(3):538-554.e5\n \n 29395908\n \n \n \n Curr Biol. 2016 Oct 24;26(20):R1022-R1038\n \n 27780045\n \n \n \n Nat Biotechnol. 2010 Apr;28(4):348-53\n \n 20231818\n \n \n \n Annu Rev Cell Dev Biol. 2009;25:161-95\n \n 19575668\n \n \n \n Nat Methods. 2011 Sep;8(9):737-43\n \n 21985007\n \n \n \n Cell. 2015 Dec 17;163(7):1756-69\n \n 26687360\n \n \n \n Cell Mol Life Sci. 2017 Nov;74(22):4133-4157\n \n 28631008\n \n \n \n Nat Commun. 2014 Jul 11;5:4342\n \n 25014658\n \n \n \n Elife. 2016 Feb 29;5:e11572\n \n 26926907\n \n \n \n J Neurosci. 2009 May 27;29(21):6904-16\n \n 19474317\n \n \n \n Gene Expr Patterns. 2006 Mar;6(3):299-309\n \n 16378756\n \n \n \n Neuron. 2008 Dec 26;60(6):1039-53\n \n 19109910\n \n \n \n Neural Dev. 2018 Apr 19;13(1):6\n \n 29673388\n \n \n \n Cell. 2015 Dec 17;163(7):1770-1782\n \n 26687361\n \n \n \n Curr Opin Neurobiol. 2014 Aug;27:1-7\n \n 24598309\n \n \n \n Curr Opin Neurobiol. 2007 Feb;17(1):35-42\n \n 17229568\n \n \n \n Nat Methods. 2012 Jun 28;9(7):676-82\n \n 22743772\n \n \n \n Genetics. 2014 Jan;196(1):17-29\n \n 24395823\n \n \n \n Cell. 1993 Jun 18;73(6):1137-53\n \n 8513498\n \n \n \n Dev Biol. 1988 Dec;130(2):645-70\n \n 3058545\n \n \n \n Elife. 2018 Mar 05;7:\n \n 29504935\n \n \n \n Science. 1995 Feb 3;267(5198):688-93\n \n 7839146\n \n \n \n Annu Rev Cell Dev Biol. 2008;24:597-620\n \n 18837673\n \n \n \n Cold Spring Harb Perspect Biol. 2010 Mar;2(3):a001735\n \n 20300210\n \n \n \n Cell Rep. 2017 Oct 24;21(4):867-877\n \n 29069594\n \n \n \n J Neurosci. 1989 Feb;9(2):710-25\n \n 2563766\n \n \n \n Neuron. 2015 May 20;86(4):955-970\n \n 25959734\n \n \n \n Elife. 2018 Mar 22;7:\n \n 29565247\n \n \n \n Brain Res. 1977 Aug 26;132(2):197-208\n \n 890480\n \n \n \n Neuron. 2017 Mar 22;93(6):1388-1404.e10\n \n 28285823\n \n \n \n Neuron. 2013 Oct 2;80(1):12-34\n \n 24094100\n \n \n \n Trends Neurosci. 2001 May;24(5):251-4\n \n 11311363\n \n \n \n Curr Opin Neurobiol. 2013 Dec;23(6):1018-26\n \n 23932598\n \n \n \n Genetics. 2016 Aug;203(4):1613-28\n \n 27334272\n \n \n \n Curr Opin Neurobiol. 2006 Feb;16(1):74-82\n \n 16386415\n \n \n \n Cell Rep. 2015 Mar 3;10(8):1410-21\n \n 25732830\n \n \n \n Cell. 1998 May 15;93(4):581-91\n \n 9604933\n \n \n \n J Comp Neurol. 2012 Jun 1;520(8):1629-49\n \n 22120935\n \n \n \n Neuron. 2018 Dec 19;100(6):1385-1400.e6\n \n 30467080\n \n \n \n PLoS Biol. 2003 Nov;1(2):E41\n \n 14624243\n \n \n \n Int J Dev Neurosci. 2001 Apr;19(2):175-82\n \n 11255031\n \n \n \n Nat Methods. 2012 Jul;9(7):671-5\n \n 22930834\n \n \n \n J Neurophysiol. 2004 May;91(5):2353-65\n \n 14695352\n \n \n \n Neuron. 2018 Dec 19;100(6):1369-1384.e6\n \n 30467079\n \n \n \n Elife. 2015 Mar 31;4:\n \n 25824290\n \n \n \n \n
\n \n
", "items": [ { "itemType": "journalArticle", "title": "Stereotyped terminal axon branching of leg motor neurons mediated by IgSF proteins DIP-α and Dpr10", "creators": [ { "firstName": "Lalanti", "lastName": "Venkatasubramanian", "creatorType": "author" }, { "firstName": "Zhenhao", "lastName": "Guo", "creatorType": "author" }, { "firstName": "Shuwa", "lastName": "Xu", "creatorType": "author" }, { "firstName": "Liming", "lastName": "Tan", "creatorType": "author" }, { "firstName": "Qi", "lastName": "Xiao", "creatorType": "author" }, { "firstName": "Sonal", "lastName": "Nagarkar-Jaiswal", "creatorType": "author" }, { "firstName": "Richard S.", "lastName": "Mann", "creatorType": "author" } ], "date": "2019-02-04", "DOI": "10.7554/eLife.42692", "ISSN": "2050-084X", "abstractNote": "For animals to perform coordinated movements requires the precise organization of neural circuits controlling motor function. Motor neurons (MNs), key components of these circuits, project their axons from the central nervous system and form precise terminal branching patterns at specific muscles. Focusing on the Drosophila leg neuromuscular system, we show that the stereotyped terminal branching of a subset of MNs is mediated by interacting transmembrane Ig superfamily proteins DIP-α and Dpr10, present in MNs and target muscles, respectively. The DIP-α/Dpr10 interaction is needed only after MN axons reach the vicinity of their muscle targets. Live imaging suggests that precise terminal branching patterns are gradually established by DIP-α/Dpr10-dependent interactions between fine axon filopodia and developing muscles. Further, different leg MNs depend on the DIP-α and Dpr10 interaction to varying degrees that correlate with the morphological complexity of the MNs and their muscle targets.", "extra": "PMID: 30714901\nPMCID: PMC6391070", "journalAbbreviation": "Elife", "language": "eng", "pages": "e42692", "publicationTitle": "eLife", "volume": "8", "attachments": [ { "title": "PubMed entry", "mimeType": "text/html", "snapshot": false } ], "tags": [ { "tag": "Animals" }, { "tag": "Axons" }, { "tag": "D. melanogaster" }, { "tag": "DIP" }, { "tag": "Dpr" }, { "tag": "Drosophila Proteins" }, { "tag": "Drosophila melanogaster" }, { "tag": "Ig domain proteins" }, { "tag": "Motor Neurons" }, { "tag": "Neurogenesis" }, { "tag": "Neurons, Efferent" }, { "tag": "Neuropeptides" }, { "tag": "Transcription Factors" }, { "tag": "developmental biology" }, { "tag": "leg development" }, { "tag": "motor neuron" }, { "tag": "neuroscience" }, { "tag": "synapse formation" } ], "notes": [], "seeAlso": [] } ] }, { "type": "import", "input": "\n\n\n\n \n 29292925\n \n 2018\n 01\n 02\n \n
\n \n 1652-7518\n \n 114\n \n 2017\n Nov\n 09\n \n \n Lakartidningen\n Lakartidningen\n \n \n EWLS\n \n Mental illness and terrorism There is little evidence supporting the concept of mental illness as a part of, or reason behind radicalization towards violent extremism and terrorism. There is weak evidence that lone gunmen, particularly those involved in school shootings, may suffer from mental illness to a larger degree than the general population, whereas organized terrorist groups such as jihadists and right-wing extremists seem to avoid mentally unstable individuals. Clinical use of the instruments developed for screening and risk assessment of individuals suspected of radicalization towards violent extremism will compromise the trust placed in the Swedish health care system by the citizens it is there to serve. The usage of empirically grounded risk assessment instruments should be restricted to forensic psychiatric clinics. Individuals at risk of radicalization towards violent extremism who present signs and symptoms of mental illness should be offered psychiatric treatment.\n \n \n \n Köhler\n Per\n P\n \n n/a - Vuxenpsykiatrin Malmö Malmö, Sweden n/a - Vuxenpsykiatrin Malmö Malmö, Sweden.\n \n \n \n Krona\n Hedvig\n H\n \n Lunds Universitet - Medicinska fakulteten Lund, Sweden Lunds Universitet - Medicinska fakulteten Lund, Sweden.\n \n \n \n Josefsson\n Johanna\n J\n \n Psykiatri Skåne - Vuxenpsykiatriska kliniken Malmö Malmö, Sweden Psykiatri Skåne - Vuxenpsykiatriska kliniken Malmö Malmö, Sweden.\n \n \n \n swe\n \n English Abstract\n Journal Article\n \n Psykisk ohälsa, radikalisering och terrorism - Inget säkert samband har kunnat påvisas.\n \n 2017\n 11\n 09\n \n
\n \n Sweden\n Lakartidningen\n 0027707\n 0023-7205\n \n
\n
\n\n
\n", "items": [ { "itemType": "journalArticle", "title": "Psykisk ohälsa, radikalisering och terrorism - Inget säkert samband har kunnat påvisas", "creators": [ { "firstName": "Per", "lastName": "Köhler", "creatorType": "author" }, { "firstName": "Hedvig", "lastName": "Krona", "creatorType": "author" }, { "firstName": "Johanna", "lastName": "Josefsson", "creatorType": "author" } ], "date": "2017-11-09", "ISSN": "1652-7518", "abstractNote": "Mental illness and terrorism There is little evidence supporting the concept of mental illness as a part of, or reason behind radicalization towards violent extremism and terrorism. There is weak evidence that lone gunmen, particularly those involved in school shootings, may suffer from mental illness to a larger degree than the general population, whereas organized terrorist groups such as jihadists and right-wing extremists seem to avoid mentally unstable individuals. Clinical use of the instruments developed for screening and risk assessment of individuals suspected of radicalization towards violent extremism will compromise the trust placed in the Swedish health care system by the citizens it is there to serve. The usage of empirically grounded risk assessment instruments should be restricted to forensic psychiatric clinics. Individuals at risk of radicalization towards violent extremism who present signs and symptoms of mental illness should be offered psychiatric treatment.", "extra": "PMID: 29292925", "journalAbbreviation": "Lakartidningen", "language": "swe", "pages": "EWLS", "publicationTitle": "Lakartidningen", "volume": "114", "attachments": [ { "title": "PubMed entry", "mimeType": "text/html", "snapshot": false } ], "tags": [], "notes": [], "seeAlso": [] } ] } ] /** END TEST CASES **/